Aemetis (NASDAQ:AMTX) Upgraded to “Sell” at StockNews.com

Aemetis (NASDAQ:AMTX) was upgraded by investment analysts at StockNews.com to a “sell” rating in a research report issued to clients and investors on Wednesday.

Separately, HC Wainwright restated a “buy” rating and set a $28.00 price objective on shares of Aemetis in a research note on Monday, December 23rd. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and four have assigned a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and a consensus price target of $12.95.

Aemetis Price Performance

Shares of NASDAQ AMTX opened at $2.16 on Wednesday. The stock has a market capitalization of $107.44 million, a P/E ratio of -0.96 and a beta of 1.44. Aemetis has a 1-year low of $2.04 and a 1-year high of $7.03. The business has a fifty day moving average price of $2.85 and a 200 day moving average price of $2.86.

Aemetis (NASDAQ:AMTX) last issued its quarterly earnings data on Tuesday, November 12th. The specialty chemicals company reported ($0.38) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.47) by $0.09. The company had revenue of $81.44 million for the quarter, compared to analysts’ expectations of $77.79 million. During the same quarter last year, the company earned ($0.59) earnings per share. As a group, equities research analysts anticipate that Aemetis will post -2.07 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Aemetis

Hedge funds have recently modified their holdings of the company. Geode Capital Management LLC boosted its stake in shares of Aemetis by 7.7% during the 3rd quarter. Geode Capital Management LLC now owns 924,293 shares of the specialty chemicals company’s stock worth $2,126,000 after acquiring an additional 66,031 shares in the last quarter. State Street Corp boosted its stake in shares of Aemetis by 36.1% during the 3rd quarter. State Street Corp now owns 699,089 shares of the specialty chemicals company’s stock worth $1,608,000 after acquiring an additional 185,304 shares in the last quarter. Barclays PLC boosted its stake in shares of Aemetis by 274.6% during the 3rd quarter. Barclays PLC now owns 47,496 shares of the specialty chemicals company’s stock worth $109,000 after acquiring an additional 34,816 shares in the last quarter. Wellington Management Group LLP purchased a new stake in shares of Aemetis during the 3rd quarter worth about $177,000. Finally, FMR LLC boosted its stake in shares of Aemetis by 68.2% during the 3rd quarter. FMR LLC now owns 22,531 shares of the specialty chemicals company’s stock worth $52,000 after acquiring an additional 9,137 shares in the last quarter. 27.02% of the stock is owned by hedge funds and other institutional investors.

About Aemetis

Aemetis, Inc operates as a renewable natural gas and renewable fuels company. It operates through three segments: California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel. The company focuses on the operation, acquisition, development, and commercialization of technologies to produce low and negative carbon intensity renewable fuels that replace fossil-based products.